Wenjun Wang

485 total citations
34 papers, 360 citations indexed

About

Wenjun Wang is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Wenjun Wang has authored 34 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Wenjun Wang's work include Spine and Intervertebral Disc Pathology (4 papers), Ovarian function and disorders (4 papers) and Cervical and Thoracic Myelopathy (3 papers). Wenjun Wang is often cited by papers focused on Spine and Intervertebral Disc Pathology (4 papers), Ovarian function and disorders (4 papers) and Cervical and Thoracic Myelopathy (3 papers). Wenjun Wang collaborates with scholars based in China, India and United States. Wenjun Wang's co-authors include Jun Li, Yan Fu, Xiang Li, Fancai Zeng, Mary Bouxsein, Alexander G. Bruno, Dennis Anderson, Bo Cheng, Man Qin and Xin Wang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Wenjun Wang

32 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjun Wang China 11 100 83 59 51 50 34 360
Dongmei Zheng China 14 140 1.4× 99 1.2× 38 0.6× 38 0.7× 62 1.2× 33 495
Rongmao Hua China 10 145 1.4× 51 0.6× 25 0.4× 35 0.7× 59 1.2× 17 405
Olgu Enis Tok Türkiye 10 109 1.1× 31 0.4× 22 0.4× 30 0.6× 73 1.5× 29 361
Jianyong Cheng China 11 155 1.6× 52 0.6× 26 0.4× 37 0.7× 68 1.4× 21 440
Deniz Billur Türkiye 11 118 1.2× 69 0.8× 32 0.5× 70 1.4× 13 0.3× 38 343
Xiaohan Li China 12 126 1.3× 67 0.8× 39 0.7× 28 0.5× 29 0.6× 36 419
Meltem Kuruş Türkiye 12 99 1.0× 26 0.3× 27 0.5× 32 0.6× 51 1.0× 28 345
Elisabeth Bonner Austria 12 118 1.2× 97 1.2× 359 6.1× 45 0.9× 18 0.4× 15 808

Countries citing papers authored by Wenjun Wang

Since Specialization
Citations

This map shows the geographic impact of Wenjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Wang more than expected).

Fields of papers citing papers by Wenjun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Wang. The network helps show where Wenjun Wang may publish in the future.

Co-authorship network of co-authors of Wenjun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Wang. A scholar is included among the top collaborators of Wenjun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Wang. Wenjun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Xiang, Xue‐Qun Luo, Wenjun Wang, et al.. (2025). Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles. Ageing Research Reviews. 112. 102902–102902.
3.
Yin, Yonggao, et al.. (2025). The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression. Molecular Medicine. 31(1). 154–154. 10 indexed citations
4.
Wang, Wenjun, Tianhui Chen, Qulian Guo, et al.. (2025). Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy. Neuropharmacology. 274. 110439–110439. 1 indexed citations
5.
Li, Xiang, et al.. (2024). Exploring heat shock proteins as therapeutic targets for Parkinson’s disease. Biochemical Pharmacology. 230(Pt 3). 116633–116633. 5 indexed citations
6.
Shen, Hui‐Hui, Xinyan Zhang, Xing Zhang, et al.. (2023). Hypoxia-mediated chemotaxis and residence of macrophage in decidua by secreting VEGFA and CCL2 during normal pregnancy. Reproduction. 165(5). 543–555. 10 indexed citations
7.
Gao, Lingyun, et al.. (2023). The Gengnianchun recipe attenuates insulin resistance-induced diminished ovarian reserve through inhibiting the senescence of granulosa cells. Frontiers in Endocrinology. 14. 1133280–1133280. 8 indexed citations
9.
Zhang, Xue, Yan Xu, Yuelun Zhang, et al.. (2022). Factors correlated with neuropathic pain in patients with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. 68. 104213–104213. 3 indexed citations
10.
Li, Xiang, Wenjun Wang, Jianghong Yan, & Fancai Zeng. (2021). Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease. Frontiers in Neuroscience. 15. 678154–678154. 13 indexed citations
11.
Chi, Cheng, Cheng Li, Nicholas Buys, et al.. (2020). Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-Analysis. Current Hypertension Reports. 22(5). 34–34. 31 indexed citations
12.
Wang, Wenjun, Xin Zhang, Qin Li, et al.. (2019). Combined blockade of IL‐25, IL‐33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma. Respirology. 25(6). 603–612. 34 indexed citations
13.
Li, Jun, et al.. (2018). Gengnianchun Extends the Lifespan of Caenorhabditis elegans via the Insulin/IGF‐1 Signalling Pathway. Oxidative Medicine and Cellular Longevity. 2018(1). 4740739–4740739. 28 indexed citations
14.
Liu, Wenwen, Baoshan Liu, Rui Zhang, et al.. (2018). Protective effect of ALDH2 against cyclophosphamide-induced acute hepatotoxicity via attenuating oxidative stress and reactive aldehydes. Biochemical and Biophysical Research Communications. 499(1). 93–98. 30 indexed citations
15.
Li, Jun, et al.. (2017). Gengnianchun, a Traditional Chinese Medicine, Enhances Oxidative Stress Resistance and Lifespan in Caenorhabditis elegans by Modulating daf‐16/FOXO. Evidence-based Complementary and Alternative Medicine. 2017(1). 8432306–8432306. 15 indexed citations
16.
Li, Jun, et al.. (2017). A Chinese Herbal Formula, Gengnianchun, Ameliorates β‐Amyloid Peptide Toxicity in a Caenorhabditis elegans Model of Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2017(1). 7480980–7480980. 14 indexed citations
17.
Wang, Xin, Wenjun Wang, Man Qin, & Yuming Zhao. (2017). Novel FAM83H mutations in patients with amelogenesis imperfecta. Scientific Reports. 7(1). 6075–6075. 18 indexed citations
18.
Wang, Wenjun, et al.. (2017). Application of anterior debridement and reconstruction with anatomical screw-plate fixation for lumbosacral tuberculosis. Medicine. 96(26). e7103–e7103. 7 indexed citations
19.
Wang, Cheng, et al.. (2011). Itraoperative wake-up test during surgery for severe ossification of ligamentum flavum. Zhonghua chuangshang zazhi. 27(6). 501–504.
20.
Li, Jun, et al.. (2011). Gengnianchun recipe inhibits apoptosis of pheochromocytoma cells from beta-amyloid 25-35 insult, better than monotherapies and their compounds. Neural Regeneration Research. 6(36). 2815. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026